HIMS three-lens brief
Evidence-based stock research on HIMS. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price up 8.56% in the last session — a material single-day move. · Analyst mean target $24.69 — 19% below current (13 analysts).
- Price up 8.56% in the last session — a material single-day move.
- Outperforming SPY by 21.0pp over 30 days.
- Analyst mean target $24.69 — 19% below current (13 analysts).
- Debt-to-equity of 207.2 — balance-sheet-heavy.
HIMS closed at $30.56 (+8.56%) as of 2026-04-25. Market cap: $6.97B. P/E (trailing) 59.9. Positives: price up 8.56% in the last session — a material single-day move.; outperforming SPY by 21.0pp over 30 days.. Concerns: analyst mean target $24.69 — 19% below current (13 analysts).; debt-to-equity of 207.2 — balance-sheet-heavy.. Last quarter: Revenue $617.82M, net income $20.60M, free cash flow $110.51M.
Why three lenses on HIMS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HIMSacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HIMS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HIMS brief"></iframe>